Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland.
AJNR Am J Neuroradiol. 2012 Dec;33(11):2038-42. doi: 10.3174/ajnr.A3123. Epub 2012 Jun 14.
While the number of CTA examinations is continually increasing compared with DSA examinations, there is little comparative dose information about the different imaging techniques. We compared patient radiation exposure resulting from diagnostic CTA and DSA examinations for both cerebral and cervicocerebral vessels.
An anthropomorphic phantom was irradiated by using typical diagnostic CTA and DSA setups and imaging parameters. For both imaging techniques, the imaging area of cerebral vessels included intracranial vessels only, while the imaging area of cervicocerebral vessels included both cervical and intracranial vessels from the aortic arch to the vertex. The effective dose was determined by using RPLDs. The DSA examination was simulated by using a biplane angiography system, and the CTA examination, by using a 64-row multidetector CT scanner.
For the imaging of cerebral vessels, the effective dose according to ICRP 103 was 0.67 mSv for CTA and 2.71 mSv for DSA. For the imaging of cervicocerebral vessels, the effective dose was 4.85 mSv for CTA and 3.60 mSv for DSA. The maximum absorbed dose (milligray) for skin, brain, salivary glands, and eyes was 166.2, 73.5, 35.6, and 21.8 mGy for DSA and 19.0, 16.9, 20.4, and 14.8 mGy for CTA, respectively. The conversion factors from DAP and DLP to effective dose were calculated.
The effective dose for CTA assessment of cerebral vessels was approximately one-fifth the dose compared with DSA. In the imaging of cervicocerebral vessels, the effective dose for CTA was approximately one-third higher compared with DSA.
与 DSA 检查相比,CTA 检查的数量持续增加,但关于不同成像技术的比较剂量信息却很少。我们比较了脑部和颈脑血管的诊断性 CTA 和 DSA 检查的患者辐射暴露情况。
使用典型的 CTA 和 DSA 设备和成像参数对人体模型进行照射。对于这两种成像技术,脑部血管的成像区域仅包括颅内血管,而颈脑血管的成像区域包括从主动脉弓到头顶的颈内和颅内血管。通过使用 RPLD 确定有效剂量。DSA 检查通过使用双平面血管造影系统进行模拟,而 CTA 检查则通过使用 64 排多排 CT 扫描仪进行模拟。
对于脑部血管成像,根据 ICRP 103 计算,CTA 的有效剂量为 0.67 mSv,DSA 的有效剂量为 2.71 mSv。对于颈脑血管成像,CTA 的有效剂量为 4.85 mSv,DSA 的有效剂量为 3.60 mSv。皮肤、大脑、唾液腺和眼睛的最大吸收剂量(毫戈瑞)分别为 166.2、73.5、35.6 和 21.8 mGy 用于 DSA,19.0、16.9、20.4 和 14.8 mGy 用于 CTA。计算了从 DAP 和 DLP 到有效剂量的转换因子。
与 DSA 相比,CTA 评估脑部血管的有效剂量约为五分之一。在颈脑血管成像中,与 DSA 相比,CTA 的有效剂量约高三分之一。